New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 17, 2012
10:27 EDTVLO, ITRI, AIMC, HFC, MHS, ARTC, SJM, RP, UPL, ACOR, DELL, HSP, JWN, MXWLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Dell (DELL) downgraded to Neutral from Outperform at RW Baird...Maxwell Tech (MXWL) downgraded to Neutral from Outperform at RW Baird...Hospira (HSP) downgraded to Sell from Neutral at Citigroup...Acorda Therapeutics (ACOR) downgraded to Neutral from Buy at Citigroup...Nordstrom (JWN) downgraded to Underperform from Buy at CLSA...ArthroCare (ARTC) downgraded to Hold from Buy at Jefferies...Altra Holdings (AIMC) downgraded to Hold from Buy at Jefferies...Ultra Petroleum (UPL) downgraded to Hold from Buy at Jefferies...Medco Health (MHS) downgraded to Equal Weight from Overweight at Morgan Stanley...Itron (ITRI) downgraded to Hold from Buy at KeyBanc...RealPage (RP) downgraded to Sector Perform from Outperform at Pacific Crest...HollyFrontier (HFC) downgraded to Neutral from Buy at UBS...Valero Energy (VLO) downgraded to Neutral from Buy at UBS...J.M. Smucker (SJM) downgraded to Buy from Conviction Buy at Goldman.
News For DELL;MXWL;HSP;ACOR;JWN;ARTC;AIMC;UPL;MHS;ITRI;RP;HFC;VLO;SJM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 17, 2014
07:19 EDTVLO, HFCIndependent Refiners sector cut to Market Weight at Wells Fargo
Subscribe for More Information
07:14 EDTHFCHollyFrontier downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information
06:59 EDTHFC, VLOMarathon Petroleum, Valero, HollyFrontier made bids for Citgo, Reuters says
Subscribe for More Information
December 15, 2014
10:00 EDTHFCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: UPS (UPS) downgraded to Hold from Buy at Deutsche Bank... CGG SA (CGG) downgraded to Underperform from Market Perform at Raymond James... Ford (F) downgraded to Hold from Buy at Deutsche Bank... Cenovus Energy (CVE) downgraded to Market Perform from Outperform at BMO Capital... Cobalt (CIE) downgraded to Neutral from Buy at Goldman... Gastar Exploration (GST) downgraded to Neutral from Buy at SunTrust... Itau Unitbanco (ITUB) downgraded to Neutral from Buy at Goldman... Methanex (MEOH) downgraded to Outperform from Strong Buy at Raymond James... OGE Energy (OGE) downgraded to Hold from Buy at Jefferies... SandRidge Energy (SD) downgraded to Neutral from Buy at SunTrust... Sempra Energy (SRE) downgraded to Neutral from Overweight at JPMorgan... HollyFrontier (HFC) downgraded to Neutral from Buy at BofA/Merrill... CNA Financial (CNA) downgraded to Market Perform from Outperform at William Blair... Allergan (AGN) downgraded to Hold from Buy at Stifel... RF Micro Devices (RFMD) downgraded to Neutral from Buy at DA Davidson.
07:08 EDTACORAcorda Therapeutics announces initiation of Phase 3 dalfampridine trial
Subscribe for More Information
06:56 EDTHFCHollyFrontier downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
December 11, 2014
07:13 EDTHSPDanone to discuss whether to keep or sell medical nutrition unit, Reuters says
According to a source, Danone (DANOY) will hold a board meeting today to discuss whether to keep or sell its medical nutrition business, Reuters reports. Previous reports said Danone's board would decide whether to sell the unit to Hospira (HSP) or Fresenius (FMS), with Fresenius as the possible front-runner to enter exclusive talks. Reference Link
December 10, 2014
17:07 EDTSJMJ.M. Smucker announces price increases on K-cup packs
The J. M. Smucker Company announced that it is increasing the list price on its K-Cup packs sold in the United States under the Folgers, Folgers Gourmet Selections, Cafe Bustelo, and Millstone brand names. Prices will increase an average of 8%. The price increase, which will be effective on January 5, 2015, is in response to sustained increases in costs.
07:45 EDTUPLWells Fargo to hold a symposium
2014 Wells Fargo Energy Symposium is being held in New York on December 9-10; with webcasted company presentations to begin on December 10 at 8 am; not all company presentations may be webcasted. Webcast Link
07:02 EDTACORAcorda Therapeutics announces initiation of Phase 3 CVT-301 trial
Subscribe for More Information
December 9, 2014
13:08 EDTHSPMerck may have paid $2B-$3B too much for Cubist, analyst says
Subscribe for More Information
08:23 EDTHSPMerck has 'no way out' of Cubist deal after court decision, says Leerink
Subscribe for More Information
08:12 EDTHSPMerck still sees Cubist acquisition neutral to modestly accretive to 2015 EPS
Merck (MRK) issued the following statement regarding the decision of the U.S. District Court for the District of Delaware. The decision, which upheld the patent for CUBICIN that expires on June 15, 2016 and invalidated four others, is subject to appeal. The company continues to believe the acquisition of Cubist (CBST) will create strong fundamental value for Merckís shareholders. The combined strength of both companies will provide both incremental and long-term value, and Merck expects the transaction to add more than $1B of revenue to its 2015 base, with strong growth potential thereafter. The courtís decision does not change Merckís expectation that the transaction will be neutral to modestly accretive to 2015 non-GAAP EPS. The company also continues to expect that the transaction will contribute mid-single digit accretion on a percentage basis to non-GAAP EPS in 2016, and will continue to be accretive thereafter.
December 8, 2014
19:00 EDTHSPCubist CEO says Cubicin patent ruling will not affect Merck transaction
Subscribe for More Information
18:24 EDTHSPOn The Fly: After Hours Movers
Subscribe for More Information
18:00 EDTHSPCubist loses bid to stop Hospira's generic Cubicin after 2016, Bloomberg says
Cubist's (CBST) patent for Cubicin that expires in June 2016 upheld by judge, Bloomberg added. Note that this morning Merck (MRK) and Cubist Pharmaceuticals announced that the companies have entered into a definitive agreement under which Merck will acquire Cubist for $102 per share in cash.
17:54 EDTHSPFour Cubist Cubicin patents invalidated as Hospira wins ruling, Bloomberg says
Subscribe for More Information
17:30 EDTHSPMerck shares lower after reports of judge decision in Cubist/Hospira case
Subscribe for More Information
17:03 EDTHSPJudge may have found in favor of Hospira in Cubist case,CNBC's Meg Tirrell says
CNBC's Meg Tirrell said in a tweet: "Whoa. $CBST Hospira decision out -- "appears judge may have found in favor of Hospira on several points," ISI's @MarkSchoenebaum says." Reference Link
08:21 EDTHSPMerck says looked at all risks, including patent litgation, before Cubist deal
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use